Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
Incorporation of two doctors to the R&D&i within the "Torres...
0 min
30/10/2020
Recruitment of two doctors for the R&D area under the Torres Quevedo Programme 2020
Recruitment of two doctors for the R&D area under the Torres Quevedo...
ROVI is a company committed to innovation, allowing it to safeguard its portfolio composed of over 500 patent dossiers, 408 of which have...
1 min
30/10/2020
ROVI holds its 2020 General Shareholders' Meeting
ROVI holds its 2020 General Shareholders' Meeting
Today, Laboratorios Farmacéuticos Rovi, S.A. held its General Shareholders’ Meeting, where the year 2019, marked by significant growth, was...
5 min
20/10/2020